ClinicalTrials.Veeva

Menu

The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer

Sun Yat-sen University logo

Sun Yat-sen University

Status

Completed

Conditions

Bladder Cancer
Immunotherapy
Radiomics

Study type

Observational

Funder types

Other

Identifiers

NCT06381895
SYSKY-2023-467-01

Details and patient eligibility

About

The aim of this study was to develop an radiomic model based on CT images to evaluate markers of the bladder cancer microenvironment, such as TSR,TIL, and IP. Secondly, the association of the radiomic model with clinical outcomes and immunotherapy response was investigated.

Enrollment

1,200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. At least 18 years of age;
  2. Performing TURB-t or RC during 2010-2022;
  3. The primary lesion was located in the bladder, and the pathological diagnosis was urothelial carcinoma;
  4. Complete clinical information, pathological data, preoperative pelvic enhanced CT and follow-up records;

Exclusion criteria

  1. Patients with distant metastasis;
  2. Combined with other malignant tumors or malignant tumor treatment history
  3. Malignant tumors of upper urinary tract;
  4. Clinical information, pathological data, preoperative pelvic enhanced CT and follow-up records were missing;
  5. Other situations in which the researcher considers it inappropriate to participate in this study.

Trial design

1,200 participants in 3 patient groups

1
Description:
Sun Yat-sen Memorial Hospital cohort
2
Description:
Third Affiliated Hospital of Sun Yat-sen University cohort
3
Description:
Sun Yat-sen University Cancer Center cohort

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems